10 minute read
Jan. 9, 2024
Acoramidis: A Potential Best-in-Class TTR Stabilizer Submitted for FDA Approval in 2023
acoramidis
oral TTR stabilizer efficacy in Ph. III in ATTR-CM hit from HTS for TTR ligands + opt. Press Release, July 17, 2023 BridgeBio, Palo Alto, CA
Author:
Editor:
Loading...
